scholarly article | Q13442814 |
P356 | DOI | 10.1160/TH06-05-0287 |
P698 | PubMed publication ID | 16953276 |
P50 | author | Vittorio Pengo | Q42778559 |
Sabino Iliceto | Q61165243 | ||
P2093 | author name string | Franco Noventa | |
Teresa Del Ross | |||
Francesco Tona | |||
Amelia Ruffatti | |||
Marta Tonello | |||
Chiara Grava | |||
Anna Cavazzana | |||
P433 | issue | 3 | |
P921 | main subject | antiphospholipid syndrome | Q582207 |
primary antiphospholipid syndrome | Q63878006 | ||
P304 | page(s) | 337-341 | |
P577 | publication date | 2006-09-01 | |
P1433 | published in | Thrombosis and Haemostasis | Q15724413 |
P1476 | title | Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity | |
P478 | volume | 96 |
Q92351181 | A modern reassessment of glycoprotein-specific direct platelet autoantibody testing in immune thrombocytopenia |
Q37832035 | APS--controversies in diagnosis and management, critical overview of current guidelines. |
Q35926536 | APhL antibody ELISA as an alternative to anticardiolipin test for the diagnosis of antiphospholipid syndrome. |
Q38876334 | Additional Treatments for High-Risk Obstetric Antiphospholipid Syndrome: a Comprehensive Review |
Q35756040 | Antiphospholipid Syndrome during pregnancy: the state of the art |
Q38655669 | Apheresis in high risk antiphospholipid syndrome pregnancy and autoimmune congenital heart block. |
Q37228076 | Association between antiphospholipid antibodies and all-cause mortality among end-stage renal disease patients with and without SLE: a retrospective cohort study |
Q38657043 | Clinical Risk Assessment in the Antiphospholipid Syndrome: Current Landscape and Emerging Biomarkers |
Q33939826 | Diagnosis of antiphospholipid syndrome in routine clinical practice |
Q64043122 | Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study |
Q97652805 | Functional lupus anticoagulant testing in a large retrospective cohort of thrombosis patients with direct oral anticoagulants |
Q95592748 | Lupus nephritis |
Q87774110 | Management of very high risk pregnancy with secondary anti-phospholipid syndrome and triple positivity to the anti-phospholipid antibodies |
Q35977256 | Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies |
Q39027911 | Prevention of thrombosis in antiphospholipid syndrome |
Q38016378 | Recurrent miscarriage, antiphospholipid antibodies and the risk of thromboembolic disease |
Q41922298 | Recurrent thrombosis prevention with intravenous immunoglobulin and hydroxychloroquine during pregnancy in a patient with history of catastrophic antiphospholipid syndrome and pregnancy loss |
Q53096573 | Role of anticardiolipin antibodies in the pathogenesis of prosthetic valve thrombosis: An observational study. |
Q92667904 | Stratifying management of rheumatic disease for pregnancy and breastfeeding |
Q38497348 | The antiphospholipid syndrome: a large elephant with many parts or an elusive chameleon disguised by many colours? |
Q38873953 | The antiphospholipid syndrome: from pathophysiology to treatment. |
Q34402456 | The relationship between mean platelet volume and thrombosis recurrence in patients diagnosed with antiphospholipid syndrome |
Q38135335 | Top 10 clinical research developments in antiphospholipid syndrome |
Q35308972 | Treatment of the antiphospholipid syndrome |
Search more.